Strengths

Attractive valuation with low multiples: P/E of 6.1x, P/S of 0.34x, and EV/Sales of 0.62x.

Solid liquidity and balance sheet support operations, with a current ratio of 2.35x and quick ratio of 1.53x.

Healthy profitability and cash generation remain intact, including ROE of 21.3%, FCF yield of 11.9%, and earnings yield of 16.2%.

Weaknesses

Operating margins remain modest, with EBIT margin at 8.6% and net margin at 5.6%.

Leverage is still meaningful, with net debt to EBITDA at 2.45x and debt to equity at 1.52x.

Free cash flow conversion is not ideal, as capex consumes about 33.8% of operating cash flow and free cash flow to equity is negative.

Opportunities

Valuation could rerate if the company sustains current earnings and cash flow, given the low earnings and free cash flow multiples.

Improving working capital efficiency could support cash generation, with a cash conversion cycle of 72.1 days.

Moderate capital intensity leaves room for incremental margin improvement if demand and pricing remain stable.

Threats

Interest coverage is only moderate at 3.8x, leaving less cushion if borrowing costs rise or earnings soften.

Inventory and operating cycle remain elevated at 73.6 and 126.9 days, respectively, which can pressure cash flow.

The business still carries leverage and cyclical exposure, so any demand slowdown could quickly compress returns and liquidity.

Overall Score